文献速递细菌感染、耐药与抗菌药物

接种量效应对高产AmpC酶肠杆菌属细菌头孢吡肟活性的影响及耐药机制

Impact of the inoculum effect on cefepime activity against AmpC-hyperproducing Enterobacter spp.: insights into resistance mechanisms.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

该研究在62株高产AmpC酶肠杆菌属临床分离株中,采用微量肉汤稀释法比较标准(5×10^5 cfu/mL)和高接种量(5×10^6 cfu/mL)下头孢吡肟的MIC。高接种量下MIC50从1 mg/L升至8 mg/L,MIC90从8 mg/L升至256 mg/L,61.3%菌株出现接种量效应,耐药株比例从6.5%升至54.8%(P<0.001),与β-内酰胺酶活性升高相关。

要点

  • 高接种量下头孢吡肟对高产AmpC酶肠杆菌属的MIC50和MIC90显著升高。
  • 61.3%菌株出现接种量效应,耐药株比例从6.5%升至54.8%(P<0.001)。
  • 接种量效应菌株的β-内酰胺酶活性显著更高,导致头孢吡肟水解。

核心结论

  • 细菌接种量大小对高产AmpC酶肠杆菌属感染中头孢吡肟的疗效有重要影响。
  • 对于高细菌载量的感染,需要量身定制的抗菌策略以优化临床结局并减少耐药发生。

研究设计与样本

  • 研究纳入62株肠杆菌属临床分离株,采用微量肉汤稀释法在标准(5×10^5 cfu/mL)和高(5×10^6 cfu/mL)接种量下测定MIC。
  • 接种量效应定义为MIC升高8倍或以上,并进行了Kaplan-Meier生存分析和时间-杀菌试验,同时测量β-内酰胺酶活性以探究机制。

主要发现

  • 标准接种量下头孢吡肟MIC50为1 mg/L,MIC90为8 mg/L。
  • 高接种量下MIC50为8 mg/L,MIC90为256 mg/L,61.3%的分离株出现接种量效应。
  • 高接种量下头孢吡肟耐药分离株比例从6.5%升至54.8%(P<0.001)。
  • Kaplan-Meier分析证实高接种量条件下中位抑制浓度增加16倍。
  • 出现接种量效应的分离株β-内酰胺酶活性显著更高,促进头孢吡肟水解和耐药。

临床怎么用

  • 研究结果提示需关注高细菌载量感染中头孢吡肟的疗效可能下降。
  • 对于高产AmpC酶肠杆菌属感染,尤其高细菌载量时,需考虑量身定制的抗菌策略。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance among Enterobacter spp. is a significant concern in healthcare settings due to their ability to hyperproduce AmpC β-lactamase, thereby limiting therapeutic options. Cefepime is recommended for treating these infections; however, its efficacy might be compromised under high bacterial inoculum conditions. OBJECTIVES: To evaluate the inoculum effect of cefepime on AmpC-hyperproducing Enterobacter spp. clinical isolates. METHODS: MICs were determined in 62 Enterobacter spp. clinical isolates using broth microdilution at standard (5 × 105 cfu/mL) and high (5 × 106 cfu/mL) inocula. The inoculum effect was defined as an 8-fold or greater MIC increase. Kaplan-Meier survival analysis and time-kill assays were conducted, and β-lactamase activity was measured to investigate the mechanism. RESULTS: At standard inoculum, cefepime showed a MIC50 of 1 mg/L and a MIC90 of 8 mg/L. High inoculum conditions resulted in a significant increase in MIC50 (8 mg/L) and MIC90 (256 mg/L), with an inoculum effect observed in 61.3% of isolates. This effect led to a substantial rise in cefepime-resistant isolates, from 6.5% to 54.8% (P < 0.001). Kaplan-Meier analysis confirmed a 16-fold increase in median inhibitory concentration under high inoculum conditions. Time-kill assays and β-lactamase activity measurements revealed that isolates with the inoculum effect displayed significantly higher β-lactamase activity, contributing to cefepime hydrolysis and resistance. CONCLUSIONS: These findings highlight the critical impact of bacterial inoculum size on cefepime efficacy in AmpC-hyperproducing Enterobacter spp. infections. Tailored antimicrobial strategies are needed, especially for infections with high bacterial loads, to optimize clinical outcomes and minimize resistance development.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Villodres Á, Soto-Gallego C, Ortiz De La Rosa JM, et al. Impact of the inoculum effect on cefepime activity against AmpC-hyperproducing Enterobacter spp.: insights into resistance mechanisms. J Antimicrob Chemother. 2025. PMID: 40265666. doi:10.1093/jac/dkaf122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。